A blood test that could detect ovarian cancer in its early stages is to be trialled in the UK in a new study.
Running for an 18 month period, the trial will offer subjects displaying symptoms a blood test known as ROMA, which helps identify women who are at high risk. Now, researchers hope to establish whether it can help diagnose the deadly ailment early in women with persistent warning signs - like bloating, tummy pain and altered appetite.
Ovarian cancer symptoms can often be missed in the condition's early stages, which is why it's known as a "silent disease". It's the sixth most common cause of cancer death in females in the UK, with a 35 percent survival rate.
